drugset / Trial / NCT06653946

the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients

NCT06653946

Phase 4 Recruiting 716 enrolled Kafrelsheikh University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The investigators evaluated the impact of AF on different subtypes of post-alteplase hemorrhagic transformation of brain infarction.

Timeline

Start
2022-07-01
Primary completion
2024-07-01
Completion
2024-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic 0.9 mg/kg Intravenous

Indications